文献速递中医内科中药与中成药合理使用

疏风解毒胶囊治疗急性上呼吸道感染:系统评价与Meta分析

Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis.
PubMed 文献 · Integr Med Res · 2021-04-02

低确定性证据提示SFJD可缩短感冒发热咳嗽、疱疹性咽峡炎发热疱疹、急性扁桃体炎和咽炎发热咽痛持续时间并提高治愈率,未报告严重不良事件。

要点

  • SFJD联合常规药物可缩短普通感冒发热和咳嗽持续时间。
  • SFJD联合常规药物可缩短疱疹性咽峡炎发热和疱疹持续时间。
  • SFJD联合常规药物可缩短急性扁桃体炎和咽炎发热及咽痛持续时间。

核心结论

  • 低确定性证据提示SFJD可缩短AURTIs症状持续时间、提高治愈率且似乎安全。
  • 仍需高质量安慰剂对照试验确认其获益。

研究设计与样本

  • 系统评价与Meta分析,纳入比较SFJD与常规药物治疗AURTIs的RCT。
  • 数据以风险比(RR)或均数差(MD)及95%CI合成,主要结局为典型症状缓解时间。

主要发现

  • 普通感冒:SFJD联合常规药物缩短发热持续时间(MD -1.54天,95%CI [-2.15,-0.92],I²=80%,n=385,3项试验)和咳嗽持续时间(MD -1.22天,95%CI [-1.52,-0.93])。
  • 疱疹性咽峡炎:缩短发热持续时间(MD -0.68天,95%CI [-1.15,-0.21],I²=68%,n=140,2项试验)和疱疹持续时间(MD -0.99天,95%CI [-1.23,-0.76],n=386,3项试验)。
  • 急性扁桃体炎和急性咽炎:缩短发热持续时间(MD -1.13天,95%CI [-1.36,-0.90],I²=33%,n=688,7项试验)和咽痛持续时间(MD -1.13天,95%CI [-1.40,-0.86],I²=84.1%,n=1194,10项试验)。
  • SFJD还提高治愈率,范围1-5天。
  • 未报告严重不良事件。

临床怎么用

  • 对普通感冒、疱疹性咽峡炎、急性扁桃体炎和急性咽炎患者,可考虑SFJD联合常规药物以缩短发热、咳嗽、疱疹和咽痛持续时间。
  • 现有证据确定性低,临床决策需结合患者具体情况并关注后续高质量研究。

局限性

  • 证据确定性低,需高质量安慰剂对照试验确认获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shufeng Jiedu capsule has been widely used in China for acute upper respiratory tract infections (AURTIs). The aim of this study was to evaluate its effectiveness and safety for AURTIs. METHODS: Randomized controlled trials comparing SFJD with conventional drug for patients with AURTIs were included. Eight databases were searched from their inceptions to February 2021. Data was synthesized using risk ration (RR) or mean difference (MD) with their 95% confidence interval (CI). The primary outcome was resolution time of typical symptoms. RESULTS: Twenty-five RCTs involving 3410 patients were included. SFJD in combination with conventional drug was associated with; in common cold shortening the duration of fever (MD -1.54 days, 95% CI [-2.15,-0.92], I 2 = 80%, n = 385, 3 trials) and cough (MD -1.22 days, 95% CI [-1.52, -0.93]); in herpangina, shortening the duration of fever (MD -0.68 days, 95% CI [-1.15, -0.21], I2 = 68%, n = 140, 2 trials) and blistering (MD -0.99 days, 95% CI [-1.23, -0.76], n = 386, 3 trials); in acute tonsillitis and acute pharyngitis shortening the duration of fever (MD -1.13 days, 95% CI [-1.36, -0.90], I 2 = 33%, n = 688, 7 trials) and sore throat (MD -1.13 days, 95% CI [-1.40, -0.86], I 2 = 84.1%, n = 1194, 10 trials). SFJD also improving their cure rate with a range (1-5 days). No serious adverse events were reported. CONCLUSION: Low certainty evidence suggests that SFJD appears to shorten the duration of symptoms in AURTIs, improve cure rate and seems safe for application. However, high quality placebo controlled trials are warranted to confirm its benefit.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Zhang YY, Xia RY, Liang SB, et al. Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis. Integr Med Res. 2021. PMID: 33996460. doi:10.1016/j.imr.2021.100726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。